Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study

Movement Disorders

Volumn 30, Issue 10, 2015, Pages 1371-1381

  Simuni, Tanya ^ae   Caspell Garcia, Chelsea ^af   Coffey, Christopher ^af   Chahine, Lama M ^ag   Lasch, Shirley ^a   Oertel, Wolfgang H ^ah   Mayer, Geert ^ai   Högl, Birgit ^d   Postuma, Ron ^aj   Videnovic, Aleksandar ^ak   Amara, Amy Willis ^al   Marek, Ken ^a   Russell, David ^a   Factor, Stewart ^g   Hogarth, Penelope ^h   Standaert, David ⁱ   Hauser, Robert ^j   Jankovic, Joseph ^k   Stern, Matthew ^l   Chahine, Lama ^l   Leverenz, James ^l   Frank, Samuel ^m   Richard, Irene ⁿ   Seppi, Klaus ^g   Shill, Holly ^o   Fernandez, Hubert ^p   Berg, Daniela ^q   Wurster, Isabel ^q   Galasko, Douglas ^r   Mari, Zoltan ^s   Brooks, David ^t   Pavese, Nicola ^t   Barone, Paolo ^u   Isaacson, Stuart ^v   Espay, Alberto ^w   Rowe, Dominic ^x   Brandabur, Melanie ^b   Tetrud, James ^b   Liang, Grace ^f   Iranzo, Alex ^y   Tolosa, Eduardo ^y   Leary, Laura ^a   Riordan, Cheryl ^a   Rees, Linda ^b   Portillo, Alicia ^h   Lenahan, Art ^h   Williams, Karen ^c   Guthrie, Stephanie ⁱ   Rawlins, Ashlee ⁱ   Harlan, Sherry ^j   Hunter, Christine ^k   Tran, Baochan ^l   Darin, Abigail ^l   Linder, Carly ^l   Baca, Marne ^l   Venkov, Heli ^l   Thomas, Cathi Ann ^m   James, Raymond ^m   Deeley, Cheryl ⁿ   Bishop, Courtney ⁿ   Sprenger, Fabienne ^g   Willeke, Diana ^e   Obradov, Sanja ^o   Mule, Jennifer ^p   Monahan, Nancy ^p   Gauss, Katharina ^q   Fontaine, Deborah ^r   Gigliotti, Christina ^r   Arita McCoy, ^s   Dunlop, Becky ^s   Shah, Bina ^t   Ainscough, Susan ^u   James, Angela ^v   Silverstein, Rebecca ^v   Espay, Kristy ^w   Ranola, Madelaine ^x   Trenkwalder, Claudia ^h   Reith, Alastair D ^z   Struyk, Arie ^aa   Boeve, Bradley ^ab   Harvey, Brian ^ac   Comella, Cindy ^ad   Tattersall, David ^z   Kelly, Madeline ^z   Foldvary, Nancy ^p   Caspell, Chelsea ^am   Uribe, Liz ^am   Foster, Eric ^am   Gloer, Katherine ^am   Yankey, Jon ^am   Kieburtz, Karl ^am   Wilson, Renee ^am   Rudolph, Alice ^am   Casaceli, Cynthia ^am   Todd Sherer, ^am   Chowdhury, Sohini ^am   Frasier, Mark ^am   Kopil, Catherine ^am   Arnedo, Vanessa ^am   Schuff, Norbert ^an   Casalin, Paola ^ao   Malferrari, Giulia ^ao   Trojanowski, John ^ap   Shaw, Les ^ap   Singleton, Andrew ^aq   Hawkins, Keith A ^ar   more..

^a INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^b PARKINSON S INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e PARACELSUS ELENA KLINIK   (Germany)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

^m BOSTON UNIVERSITY   (United States)

ⁿ UNIVERSITY OF ROCHESTER   (United States)

^o Banner Research Institute   (United States)

^p LERNER RESEARCH INSTITUTE   (United States)

^q UNIVERSITY OF TÜBINGEN   (Germany)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s JOHNS HOPKINS UNIVERSITY   (United States)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u UNIVERSITY OF SALERNO   (Italy)

^v Parkinson's Disease and Movement Disorder Center of Boca Raton   (United States)

^w UNIVERSITY OF CINCINNATI   (United States)

^x MACQUARIE UNIVERSITY   (Australia)

^y HOSPITAL CLÍNIC   (Spain)

^z GLAXOSMITHKLINE   (United Kingdom)

^aa MERCK RESEARCH LABORATORIES   (United States)

^ab MAYO CLINIC   (United States)

^ac PFIZER INC   (United States)

^ad RUSH UNIVERSITY MEDICAL CENTER   (United States)

^ae NORTHWESTERN UNIVERSITY   (United States)

^af UNIVERSITY OF IOWA   (United States)

^ag UNIVERSITY OF PENNSYLVANIA   (United States)

^ah Gemeinnutzige Hertie Stiftung   (Germany)

^ai Hephata Klinik Hephata Hessisches Diakoniezentrum e V   (Germany)

^aj MCGILL UNIVERSITY   (Canada)

^ak MASSACHUSETTS GENERAL HOSPITAL   (United States)

^al UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^am UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^an THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^ao UNIVERSITY OF CALIFORNIA   (United States)

^ap BioRep   (Italy)

^aq NATIONAL INSTITUTE ON AGING   (United States)

^ar YALE UNIVERSITY   (United States)

more..

Author keywords

Biomarkers; Daytime somnolence; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; HYPNOTIC AGENT; SEDATIVE AGENT; TAU PROTEIN;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CASE CONTROL STUDY; COGNITION ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR DYSFUNCTION ASSESSMENT; OBSERVATIONAL STUDY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; UNIFIED PARKINSON DISEASE RATING SCALE; COMORBIDITY; DISORDERS OF EXCESSIVE SOMNOLENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84941178621     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26248     Document Type: Article

References (46)

1. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
2. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9:185-200.
3. Poewe W, Hogl B. Parkinson's disease and sleep. Curr Opin Neurol 2000;13:423-426.
4. Breen DP, Williams-Gray CH, Mason SL, Foltynie T, Barker RA. Excessive daytime sleepiness and its risk factors in incident Parkinson's disease. J Neurol Neurosurg Psychiatry 2013;84:233-234.
5. Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003;18:668-672.
6. Tan EK, Lum SY, Fook-Chong SM, et al. Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology 2002;58:465-468.
7. Hogl B, Seppi K, Brandauer E, et al. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 2003;18:319-323.
8. Kumar S, Bhatia M, Behari M. Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Med 2003;4:339-342.
9. Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 2008;23:35-41.
10. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006;67:853-858.
11. O'Suilleabhain PE, Dewey RB, Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurology 2002;59:986-989.
12. Fabbrini G, Barbanti P, Aurilia C, Pauletti C, Vanacore N, Meco G. Excessive daytime somnolence in Parkinson's disease: follow-up after 1 year of treatment. Neurol Sci 2003;24:178-179.
13. Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010;17:1428-1436.
14. Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of nonmotor symptoms in Parkinson's disease. J Neurol 2012;259:1639-1647.
15. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-1546.
16. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 2005;12:199-207.
17. Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 2002;17:1026-1030.
18. Buskova J, Klempir J, Majerova V, et al. Sleep disturbances in untreated Parkinson's disease. J Neurol 2011;258:2254-2259.
19. Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson's disease (The ONSET PD Study). Mov Disord 2015;30:229-237.
20. Erro R, Picillo M, Vitale C, et al. Nonmotor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry 2013;84:14-17.
21. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005;65:1442-1446.
22. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-134.
23. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011;95:629-635.
24. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
25. Hogl B, Arnulf I, Comella C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 2010;25:2704-2716.
26. Goetz CG. [Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease]. Rev Neurol 2010;166:1-4.
27. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord 2013;28:668-670.
28. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
29. Schwab RS EA. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ DI, ed. Third Symposium on Parkinson's Disease. Edinburgh, Scotland: E & S Livingstone; 1969:152-157.
30. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
31. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 2006;14:169-175.
32. Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol 2010;17:194-201.
33. Kendall PC, Finch AJ, Jr., Auerbach SM, Hooke JF, Mikulka PJ. The State-Trait Anxiety Inventory: a systematic evaluation. J Consult Clin Psychol 1976;44:406-412.
34. Weintraub D, Hoops S, Shea JA, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009;24:1461-1467.
35. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire: a new diagnostic instrument. Mov Disord 2007;22:2386-2393.
36. Kang JH, Irwin DJ, Chen-Plotkin AS, et al. Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 2013;70:1277-1287.
37. Vaz Fragoso CA, Van Ness PH, Araujo KL, Iannone LP, Marottoli RA. Sleep disturbances and driving practices of older drivers. J Am Geriatr Soc 2013;61:1730-1737.
38. Wegelin J, McNamara P, Durso R, Brown A, McLaren D. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinsonism Rel Disord 2005;11:441-448.
39. Buijs RM, Escobar C, Swaab DF. The circadian system and the balance of the autonomic nervous system. Handb Clin Neurol 2013;117:173-191.
40. Postuma RB, Aarsland D, Barone P, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012;27:617-626.
41. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 2008;79:1117-1121.
42. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009;72:1296-1300.
43. Mollenhauer B, Trenkwalder C, von Ahsen N, et al. Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement Geriatr Cogn Disord 2006;22:200-208.
44. Mollenhauer B, Trautmann E, Taylor P, et al. Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects. Neurosci Lett 2013;532:44-48.
45. Compta Y, Marti MJ, Ibarretxe-Bilbao N, et al. Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Mov Disord 2009;24:2203-2210.
46. Shi M, Bradner J, Hancock AM, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 2011;69:570-580.